Madrigal Pharmaceuticals, Inc. (MDGL)
514.06
-42.16
(-7.58%)
USD |
NASDAQ |
Jan 09, 16:00
513.00
-1.06
(-0.21%)
After-Hours: 06:42
Madrigal Pharmaceuticals Research and Development Expense (Annual): 235.62M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 10.99B |
| Amgen, Inc. | 5.676B |
| Pfizer Inc. | 10.74B |
| Crinetics Pharmaceuticals, Inc. | 237.37M |
| Amicus Therapeutics, Inc. | 109.36M |